Clinical Trial Update: French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

View source ↗

Summary

A French registry is enrolling children treated with Norditropin (somatropin) for short stature associated with Noonan syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noonan Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Noonan Syndrome | Status: ENROLLING_BY_INVITATION